{"id":"glucocorticoid-treatment","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Infection (bacterial, viral, fungal)"},{"rate":"variable with duration","effect":"Osteoporosis and fracture risk"},{"rate":"5-15","effect":"Hyperglycemia and diabetes"},{"rate":"5-10","effect":"Hypertension"},{"rate":"10-20","effect":"Weight gain and central obesity"},{"rate":"5-10","effect":"Mood disturbances (depression, anxiety)"},{"rate":"5-15","effect":"Insomnia"},{"rate":"1-5","effect":"Gastric ulceration"},{"rate":"variable with duration","effect":"Cataracts"},{"rate":"variable with dose and duration","effect":"Adrenal suppression"}]},"_chembl":{"chemblId":"CHEMBL7257","moleculeType":"Small molecule","molecularWeight":"218.30"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Glucocorticoids are steroid hormones that enter cells and bind to intracellular glucocorticoid receptors, translocating to the nucleus to alter transcription of inflammatory genes. They inhibit production of cytokines (IL-1, IL-6, TNF-α), reduce immune cell activation and proliferation, and stabilize lysosomal membranes. This broad immunosuppressive and anti-inflammatory action makes them effective across multiple inflammatory and autoimmune conditions.","oneSentence":"Glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene expression of pro-inflammatory cytokines and immune cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:14:02.432Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"},{"name":"Systemic lupus erythematosus"},{"name":"Polymyalgia rheumatica"},{"name":"Giant cell arteritis"},{"name":"Inflammatory bowel disease"},{"name":"Asthma and COPD exacerbations"},{"name":"Adrenal insufficiency"}]},"trialDetails":[{"nctId":"NCT05789030","phase":"NA","title":"Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2022-07-01","conditions":"Autoimmune Diseases","enrollment":60},{"nctId":"NCT05462730","phase":"PHASE2","title":"Pulse Glucocorticoid Therapy in Patients With ST-Segment Elevation Myocardial Infarction","status":"COMPLETED","sponsor":"Thomas Engstrom","startDate":"2022-11-14","conditions":"ST Elevation Myocardial Infarction, Inflammatory Response, Myocardial Reperfusion Injury","enrollment":530},{"nctId":"NCT07490964","phase":"","title":"Polycystic Ovary Syndrome in Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","startDate":"2026-04-01","conditions":"Type 1 Diabetes Mellitus, Polycystic Ovary Syndrome (PCOS)","enrollment":60},{"nctId":"NCT06934915","phase":"EARLY_PHASE1","title":"Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder","status":"NOT_YET_RECRUITING","sponsor":"Christopher John McDougle, M.D.","startDate":"2026-11","conditions":"Autism Spectrum Disorder, Autism Spectrum Disorders, Autistic Disorder","enrollment":32},{"nctId":"NCT04877691","phase":"PHASE3","title":"Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2021-06-08","conditions":"Systemic Lupus Erythematosus","enrollment":367},{"nctId":"NCT07015983","phase":"PHASE2","title":"A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)","status":"RECRUITING","sponsor":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","startDate":"2025-07-14","conditions":"Lupus Erythematosus, Systemic, Lupus Nephritis","enrollment":89},{"nctId":"NCT07175285","phase":"","title":"A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2025-10-08","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":223},{"nctId":"NCT05435781","phase":"PHASE4","title":"Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency","status":"RECRUITING","sponsor":"Marianne Christina Klose","startDate":"2022-06-07","conditions":"Adrenal Insufficiency, Polymyalgia Rheumatica, Giant Cell Arteritis","enrollment":250},{"nctId":"NCT07469332","phase":"NA","title":"Comparison of the Effects of Moderate- and High-Dose Glucocorticoids on Postoperative Recovery","status":"NOT_YET_RECRUITING","sponsor":"Ankara City Hospital Bilkent","startDate":"2026-03-30","conditions":"Postoperative Recovery, PONV","enrollment":135},{"nctId":"NCT04322357","phase":"PHASE2","title":"Twice Weekly Steroids and Exercise as Therapy for DMD","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-07-30","conditions":"Duchenne Muscular Dystrophy (DMD)","enrollment":21},{"nctId":"NCT05379634","phase":"PHASE2","title":"A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory Myopathies","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2022-07-05","conditions":"Myositis","enrollment":36},{"nctId":"NCT07340463","phase":"PHASE2","title":"The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment","status":"RECRUITING","sponsor":"Nanjing University School of Medicine","startDate":"2025-12-08","conditions":"Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)","enrollment":50},{"nctId":"NCT03661645","phase":"PHASE4","title":"Post-operative Methylprednisolone Taper Course for Orthopedic Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"Emory University","startDate":"2018-09-07","conditions":"Orthopedic Surgeries","enrollment":500},{"nctId":"NCT07453368","phase":"PHASE2","title":"Orelabrutinib in the Treatment of Relapsed/Refractory AIHA","status":"NOT_YET_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2026-03-01","conditions":"Autoimmune Hemolytic Anemia (AIHA)","enrollment":50},{"nctId":"NCT07451665","phase":"PHASE4","title":"Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis","status":"NOT_YET_RECRUITING","sponsor":"Chinese SLE Treatment And Research Group","startDate":"2026-04-01","conditions":"Takayasu Arteritis (TAK)","enrollment":180},{"nctId":"NCT05726292","phase":"PHASE2","title":"A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-01-06","conditions":"Prostate Cancer, Prostate Adenocarcinoma","enrollment":90},{"nctId":"NCT05679401","phase":"PHASE3","title":"A Study With Imlifidase in Anti-GBM Disease","status":"TERMINATED","sponsor":"Hansa Biopharma AB","startDate":"2022-12-22","conditions":"Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome","enrollment":50},{"nctId":"NCT07449494","phase":"","title":"Live Birth Rate After First Embryo Transfer With or Without Glucocorticoid Sensitivity Testing","status":"COMPLETED","sponsor":"Hopital Pierre Rouques - Les Bluets","startDate":"2020-09-01","conditions":"Infertility","enrollment":148},{"nctId":"NCT06037811","phase":"PHASE2","title":"Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis","status":"RECRUITING","sponsor":"Tom Appleton","startDate":"2024-04-15","conditions":"Inflammatory Arthritis, Immune-related Adverse Event","enrollment":30},{"nctId":"NCT07221838","phase":"PHASE4","title":"A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab","status":"NOT_YET_RECRUITING","sponsor":"Alexion Pharmaceuticals, Inc.","startDate":"2026-02-27","conditions":"Generalized Myasthenia Gravis, gMG","enrollment":75},{"nctId":"NCT06246513","phase":"PHASE3","title":"A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sarepta Therapeutics, Inc.","startDate":"2024-01-15","conditions":"Limb-girdle Muscular Dystrophy","enrollment":17},{"nctId":"NCT05674994","phase":"PHASE3","title":"Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Fondation Hôpital Saint-Joseph","startDate":"2023-10-26","conditions":"Acute Exacerbation of Idiopathic Pulmonary Fibrosis","enrollment":110},{"nctId":"NCT05380453","phase":"PHASE3","title":"Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical Remission","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2022-09-29","conditions":"Giant Cell Arteritis","enrollment":151},{"nctId":"NCT04883619","phase":"PHASE2","title":"A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis","status":"WITHDRAWN","sponsor":"Janssen Research & Development, LLC","startDate":"2026-01-15","conditions":"Lupus Nephritis","enrollment":""},{"nctId":"NCT07108387","phase":"PHASE2","title":"Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-12-11","conditions":"Giant Cell Arteritis (GCA)","enrollment":78},{"nctId":"NCT06660355","phase":"PHASE2","title":"Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2024-12-23","conditions":"Chronic Graft-versus-host Disease (cGVHD)","enrollment":120},{"nctId":"NCT04930094","phase":"PHASE3","title":"Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2021-10-06","conditions":"Giant Cell Arteritis (GCA)","enrollment":355},{"nctId":"NCT03153527","phase":"PHASE4","title":"Taper Or Abrupt Steroid Stop: TOASSTtrial","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2017-05-31","conditions":"Inflammatory Disorder, Autoimmune","enrollment":530},{"nctId":"NCT07430306","phase":"PHASE3","title":"A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"AstraZeneca","startDate":"2026-04-01","conditions":"Systemic Lupus Erythematosus","enrollment":245},{"nctId":"NCT05799755","phase":"PHASE4","title":"Myositis Interstitial Lung Disease Nintedanib Trial","status":"COMPLETED","sponsor":"Rohit Aggarwal, MD","startDate":"2023-08-01","conditions":"Myositis Associated Interstitial Lund Disease (MA-ILD)","enrollment":49},{"nctId":"NCT07268248","phase":"NA","title":"1-hour Premedication for Allergy Goal in Emergency: PAGE-1 Study","status":"NOT_YET_RECRUITING","sponsor":"Paul Peng, MD PhD MSCR","startDate":"2026-06","conditions":"Allergic Reaction to Contrast Media, Hypersensitivity Reaction, Computed Tomography","enrollment":540},{"nctId":"NCT06348147","phase":"PHASE2","title":"Dara-RVd Induction for Newly Diagnosed Multiple Myeloma With Autologous Stem Cell Transplantation","status":"SUSPENDED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2026-07","conditions":"Newly Diagnosed Multiple Myeloma, Multiple Myeloma, Autologous Stem Cell Transplantation","enrollment":39},{"nctId":"NCT07406932","phase":"NA","title":"A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome","status":"NOT_YET_RECRUITING","sponsor":"China-Japan Friendship Hospital","startDate":"2026-02-01","conditions":"Antisynthetase Syndrome, Interstitial Lung Disease (ILD)","enrollment":80},{"nctId":"NCT07258524","phase":"","title":"PET Assessment of Disease Activity and Cardiovascular Disease Risk in ANCA-associated Vasculitis","status":"RECRUITING","sponsor":"University of Edinburgh","startDate":"2026-01-28","conditions":"ANCA Associated Vasculitis (AAV)","enrollment":120},{"nctId":"NCT07297563","phase":"PHASE2","title":"Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-01-20","conditions":"Immune Thrombocytopenia, Treatment","enrollment":160},{"nctId":"NCT07234019","phase":"PHASE2","title":"Rituximab Combining Anti-CD38 Monoclonal Antibody Versus Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-01-28","conditions":"Immune Thrombocytopenia, Treatment","enrollment":160},{"nctId":"NCT06868381","phase":"PHASE2","title":"A Trial of Baricitinib in Patients With Cardiac Sarcoidosis","status":"NOT_YET_RECRUITING","sponsor":"Stanford University","startDate":"2026-04-01","conditions":"Cardiac Sarcoidosis","enrollment":10},{"nctId":"NCT07382375","phase":"NA","title":"AI-assisted Subtyping-directed Precision Treatment in Acute Aortic Dissection","status":"NOT_YET_RECRUITING","sponsor":"Nanjing Medical University","startDate":"2027-12-31","conditions":"Aortic Aneurysm and Dissection","enrollment":300},{"nctId":"NCT06983821","phase":"PHASE3","title":"Safe Effective Therapy With Low-Dose Glucocorticoid in ANCA-Associated Vasculitis (SAFE-LOW)","status":"RECRUITING","sponsor":"Ottawa Hospital Research Institute","startDate":"2025-11-10","conditions":"Granulomatosis With Polyangiitis, Microscopic Polyangiitis (MPA)","enrollment":36},{"nctId":"NCT07060638","phase":"PHASE2","title":"Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial","status":"RECRUITING","sponsor":"Samer Gawrieh","startDate":"2026-01-27","conditions":"Alcohol-associated Hepatitis","enrollment":216},{"nctId":"NCT04452500","phase":"PHASE2","title":"Phase IIa Trial of a Selective Glucocorticoid Receptor Antagonist in the Treatment of Veterans With Posttraumatic Stress Disorder (PTSD) (Seven Study)","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-10-15","conditions":"PTSD","enrollment":40},{"nctId":"NCT07377058","phase":"NA","title":"RCT of Tocilizumab for Anti-MDA5+DM","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-11-01","conditions":"Dermatomyositis","enrollment":110},{"nctId":"NCT07077486","phase":"PHASE4","title":"Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-08-25","conditions":"Lupus or SLE, Interstitial Lung Disease, Systemic Lupus Erythematosus","enrollment":100},{"nctId":"NCT06688838","phase":"","title":"Effective Treatment of Jak1/3 Inhibitor in Blau Syndrome","status":"ENROLLING_BY_INVITATION","sponsor":"Tongji Hospital","startDate":"2017-01-01","conditions":"Blau Syndrome","enrollment":24},{"nctId":"NCT07367425","phase":"NA","title":"Risks of Ramadan Fasting in Patients With Primary Adrenal Insufficiency Treated With Prednisolone.","status":"NOT_YET_RECRUITING","sponsor":"Hopital La Rabta","startDate":"2026-01-22","conditions":"Primary Adrenal Insufficiency, Ramadan Fasting, Prednisolone","enrollment":35},{"nctId":"NCT04474847","phase":"PHASE3","title":"Abatacept for the Treatment of Giant Cell Arteritis","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2021-03-29","conditions":"Giant Cell Arteritis","enrollment":78},{"nctId":"NCT07362667","phase":"","title":"A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA","status":"RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2026-01-10","conditions":"ABPA, Allergic Bronchopulmonary Aspergillosis, Allergic Bronchopulmonary Aspergillosis (ABPA)","enrollment":44},{"nctId":"NCT07362238","phase":"PHASE2","title":"Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03","conditions":"Immune Thrombocytopenia, Treatment","enrollment":122},{"nctId":"NCT07362693","phase":"","title":"A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA","status":"NOT_YET_RECRUITING","sponsor":"Qianfoshan Hospital","startDate":"2025-12-31","conditions":"ABPA, Biologics, Allergic Bronchopulmonary Aspergillosis (ABPA)","enrollment":50},{"nctId":"NCT07363733","phase":"NA","title":"Dynamic Quadripolar Radiofrequency VS Topical Corticosteroids in Women With Vulvar Lichen Sclerosus","status":"RECRUITING","sponsor":"Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare","startDate":"2026-01","conditions":"Vulvar Lichen Sclerosus","enrollment":68},{"nctId":"NCT07357935","phase":"PHASE1, PHASE2","title":"Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Qingyuan Zhan","startDate":"2026-02-01","conditions":"Acute Respiratory Failure, Community-Acquired Pneumonia","enrollment":500},{"nctId":"NCT04258293","phase":"","title":"Diabetes Screening in Patients on Long-Term Glucocorticoid Therapy","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2020-02-06","conditions":"Glucocorticosteroid, Diabetes","enrollment":75},{"nctId":"NCT07354503","phase":"","title":"Telitacicept in the Treatment of Pediatric IgA Vasculitis-Associated Nephritis","status":"NOT_YET_RECRUITING","sponsor":"The Children's Hospital of Zhejiang University School of Medicine","startDate":"2026-01-01","conditions":"IgAVN, IgA Vasculitis","enrollment":300},{"nctId":"NCT05569759","phase":"PHASE2","title":"A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)","status":"COMPLETED","sponsor":"Kezar Life Sciences, Inc.","startDate":"2023-05-23","conditions":"Autoimmune Hepatitis","enrollment":24},{"nctId":"NCT04951986","phase":"PHASE3","title":"Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2021-08-11","conditions":"Disseminated Tuberculosis, HIV","enrollment":732},{"nctId":"NCT07319598","phase":"PHASE4","title":"A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease","status":"RECRUITING","sponsor":"Peking University Third Hospital","startDate":"2023-11-02","conditions":"Interstitial Lung Disease (ILD), Connective Tissue Disease-associated Interstitial Lung Disease","enrollment":100},{"nctId":"NCT06410443","phase":"NA","title":"Efficacy and Safety of Local Glucocorticoids for the Treatment of Acute Radiation-Induced Intestinal Injury","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2024-08-01","conditions":"Radiation-Induced Intestinal Injury","enrollment":60},{"nctId":"NCT05128942","phase":"PHASE2","title":"A Phase 2 Study to Evaluate the Safety, Efficacy and PK of Tildacerfont in Children Aged 2-17 Years With CAH","status":"TERMINATED","sponsor":"Spruce Biosciences","startDate":"2021-12-10","conditions":"Congenital Adrenal Hyperplasia, 21-OHD","enrollment":67},{"nctId":"NCT07187011","phase":"PHASE2","title":"Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans","status":"NOT_YET_RECRUITING","sponsor":"San Diego Veterans Healthcare System","startDate":"2026-04-01","conditions":"PTSD - Post Traumatic Stress Disorder","enrollment":120},{"nctId":"NCT05193396","phase":"PHASE4","title":"Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment","status":"RECRUITING","sponsor":"Marianne Andersen","startDate":"2022-02-01","conditions":"Adrenal Insufficiency, Polymyalgia Rheumatica (PMR), Giant Cell Arteritis (GCA)","enrollment":100},{"nctId":"NCT06922669","phase":"NA","title":"Glucocorticoids for Acute Drug Induced Liver Injury With Hyperbilirubinemia","status":"RECRUITING","sponsor":"General Hospital of Shenyang Military Region","startDate":"2025-06-24","conditions":"Drug Induced Liver Injury","enrollment":232},{"nctId":"NCT06387121","phase":"PHASE2","title":"Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2024-04-02","conditions":"Precursor Cell Lymphoblastic Leukemia-Lymphoma","enrollment":53},{"nctId":"NCT07285889","phase":"PHASE1, PHASE2","title":"First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)","status":"RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2025-12-03","conditions":"Acute Graft Versus Host Disease","enrollment":35},{"nctId":"NCT07235904","phase":"PHASE4","title":"Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed Moderate-to-severe Ulcerative Colitis","status":"RECRUITING","sponsor":"University Hospital Schleswig-Holstein","startDate":"2025-12-05","conditions":"Ulcerative Colitis (UC)","enrollment":300},{"nctId":"NCT03983837","phase":"PHASE2","title":"Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-06-23","conditions":"Chronic Granulomatous Disease, Inflammatory Bowel Disease","enrollment":3},{"nctId":"NCT02325063","phase":"NA","title":"Evaluation of Three Types of Injection for the Treatment of Lateral Epicondylalgia","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2015-12-17","conditions":"Epicondylitis, Lateral Humeral, Tennis Elbow","enrollment":13},{"nctId":"NCT04882878","phase":"PHASE2","title":"A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-08-20","conditions":"Systemic Lupus Erythematosus","enrollment":228},{"nctId":"NCT04941404","phase":"PHASE1, PHASE2","title":"A Study of TQ05105 Tablets in Subjects With Glucocorticoid-Refractory Acute Graft-Versus-Host Disease (aGVHD)","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2022-06-10","conditions":"Glucocorticoid-Refractory aGVHD","enrollment":13},{"nctId":"NCT00706420","phase":"PHASE1","title":"Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2004-04-07","conditions":"Diabetes Mellitus","enrollment":17},{"nctId":"NCT05781750","phase":"PHASE2","title":"A Study of Zetomipzomib (KZR-616) in Patients With Active Lupus Nephritis (PALIZADE)","status":"TERMINATED","sponsor":"Kezar Life Sciences, Inc.","startDate":"2023-11-03","conditions":"Lupus Nephritis","enrollment":84},{"nctId":"NCT07265258","phase":"PHASE4","title":"A Study of Teprotumumab N01 in Subjects With Active Thyroid Eye Disease","status":"NOT_YET_RECRUITING","sponsor":"Innovent Biologics (Suzhou) Co. Ltd.","startDate":"2025-12-30","conditions":"Thyroid Eye Disease","enrollment":92},{"nctId":"NCT03511196","phase":"EARLY_PHASE1","title":"Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-09-17","conditions":"Prostate Cancer, Stage IV Prostate Cancer, Advanced Prostate Cancer","enrollment":17},{"nctId":"NCT05190770","phase":"PHASE2","title":"A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2021-12-15","conditions":"Breast Cancer, Breast Cancer Stage, Breast Cancer Stage I","enrollment":18},{"nctId":"NCT05879419","phase":"PHASE4","title":"Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Sao Paulo General Hospital","startDate":"2023-05-23","conditions":"Rheumatoid Arthritis, Spondylitis, Ankylosing, Spondyloarthritis","enrollment":2005},{"nctId":"NCT06270719","phase":"","title":"An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy","status":"ENROLLING_BY_INVITATION","sponsor":"Sarepta Therapeutics, Inc.","startDate":"2024-02-07","conditions":"Duchenne Muscular Dystrophy","enrollment":500},{"nctId":"NCT07080346","phase":"PHASE2","title":"Upadacitinib for Refractory Behcet's Syndrome","status":"COMPLETED","sponsor":"Liu Tian","startDate":"2024-01-25","conditions":"Behcet Syndrome","enrollment":27},{"nctId":"NCT02997605","phase":"PHASE4","title":"Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients","status":"COMPLETED","sponsor":"University Hospital, Toulouse","startDate":"2017-01-31","conditions":"RheumatoId Arthritis","enrollment":102},{"nctId":"NCT06047171","phase":"PHASE2","title":"Rescue of Nephrons With ALE.F02 (RENAL-F02)","status":"RECRUITING","sponsor":"Alentis Therapeutics AG","startDate":"2023-09-07","conditions":"Glomerulonephritis Rapidly Progressive","enrollment":80},{"nctId":"NCT03164473","phase":"PHASE3","title":"Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-03-07","conditions":"Eosinophilic Granulomatosis With Polyangiitis","enrollment":98},{"nctId":"NCT06072768","phase":"PHASE2","title":"Dynamic Treatment Regiments for Glucocorticoid Tapering","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-03-09","conditions":"Rheumatoid Arthritis","enrollment":200},{"nctId":"NCT05860400","phase":"","title":"Efficacy and Safety of Comprehensive Treatment in Patients With IR-CAD: a Self-controlled Cohort Study","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-05-17","conditions":"Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis","enrollment":39},{"nctId":"NCT06845410","phase":"","title":"Clinical Features, Current Treatment and Clinical Outcomes in Patients With INR-CAD: a Cohort Study","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2025-04-01","conditions":"Coronary Artery Disease, Coronary Artery Disease Progression, Coronary Artery Stenosis","enrollment":120},{"nctId":"NCT07227584","phase":"PHASE2","title":"ALL Backbone in AYAs","status":"NOT_YET_RECRUITING","sponsor":"Dana-Farber Cancer Institute","startDate":"2026-04","conditions":"Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL)","enrollment":67},{"nctId":"NCT06462781","phase":"PHASE1","title":"Localized Injection of Lidocaine and Glucocorticoid for Headache Treatment Phase 1","status":"COMPLETED","sponsor":"The Cooper Health System","startDate":"2024-03-15","conditions":"Refractory Migraine","enrollment":10},{"nctId":"NCT05101213","phase":"PHASE1","title":"Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2023-01-06","conditions":"Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection","enrollment":30},{"nctId":"NCT07210008","phase":"PHASE3","title":"\"Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity Pneumonitis\"","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-06-01","conditions":"Hypersensitivity Pneumonitis","enrollment":120},{"nctId":"NCT05428488","phase":"PHASE3","title":"Efficacy of a Sequential Treatment Strategy in Rheumatoid Arthritis","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2022-11-28","conditions":"Rheumatoid Arthritis","enrollment":220},{"nctId":"NCT07049172","phase":"NA","title":"Rituximab and Targeted Nursing for Pediatric Nephrotic Syndrome","status":"COMPLETED","sponsor":"Wuhan Children's Hospital","startDate":"2021-01-01","conditions":"Nephrotic Syndrome in Children","enrollment":91},{"nctId":"NCT07010484","phase":"","title":"Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica","status":"RECRUITING","sponsor":"Kresten Krarup Keller","startDate":"2025-08-21","conditions":"Polymyalgia Rheumatica (PMR)","enrollment":149},{"nctId":"NCT04875702","phase":"PHASE4","title":"Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-02-22","conditions":"Gout","enrollment":650},{"nctId":"NCT07189910","phase":"PHASE4","title":"Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2025-12-01","conditions":"Primary Immune Thrombocytopenia (ITP)","enrollment":150},{"nctId":"NCT05542381","phase":"NA","title":"The Role of Loteprednol in Reducing Post-Intravitreal Injection Related Pain","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2022-12-22","conditions":"Age-Related Macular Degeneration","enrollment":64},{"nctId":"NCT03760835","phase":"PHASE4","title":"Congenital Adrenal Hyperplasia Once Daily Hydrocortisone Treatment","status":"RECRUITING","sponsor":"Federico II University","startDate":"2016-08-11","conditions":"Congenital Adrenal Hyperplasia","enrollment":150},{"nctId":"NCT03290456","phase":"NA","title":"Evaluate the Remission MAINtenance Using Extended Administration of Prednisone in Systemic Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis.","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2019-08-20","conditions":"Granulomatosis With Polyangitis","enrollment":146},{"nctId":"NCT03815019","phase":"PHASE4","title":"iKanEat: A Randomized-controlled, Multi-center Trial of Megestrol for Chronic Oral Food Refusal in Children","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2019-08-15","conditions":"Feeding Behavior, Feeding Disorder of Infancy or Early Childhood","enrollment":70},{"nctId":"NCT06609668","phase":"","title":"Pilot Study to evaluateThrombomodulin to Rule Out Giant Cell Arteritis (GCA) in Polymyalgia Rheumatica (PMR) Patients. (THROPIQ)","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2024-10-10","conditions":"Giant Cell Arteritis (GCA), Polymyalgia Rheumatica (PMR)","enrollment":78},{"nctId":"NCT05438875","phase":"PHASE3","title":"The Combination of ATRA and Eltrombopag as the Treatment of Steroid-resistant/Relapse ITP Based on MSC-C5b-9","status":"COMPLETED","sponsor":"Peking University People's Hospital","startDate":"2022-10-12","conditions":"Purpura, Thrombocytopenic, Idiopathic","enrollment":96},{"nctId":"NCT07159906","phase":"PHASE1, PHASE2","title":"Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2025-09-08","conditions":"Diffuse Large B-Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma","enrollment":62},{"nctId":"NCT07159893","phase":"NA","title":"Inectolizumab With Steroid Optimization in Newly Treated NMOSD","status":"NOT_YET_RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2025-09","conditions":"Neuromyelitis Optica, Autoimmune Diseases, Demyelinating Autoimmune Diseases, CNS","enrollment":25},{"nctId":"NCT06385509","phase":"PHASE4","title":"A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO® for 12 Months","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tolmar Inc.","startDate":"2024-05-10","conditions":"Hypogonadism","enrollment":110}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3871,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["prednis(ol)one, methylprednisolone"],"phase":"phase_3","status":"active","brandName":"Glucocorticoid treatment","genericName":"Glucocorticoid treatment","companyName":"Prof Dr Frank Buttgereit","companyId":"prof-dr-frank-buttgereit","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Glucocorticoids suppress immune and inflammatory responses by binding to glucocorticoid receptors and modulating gene expression of pro-inflammatory cytokines and immune cells. Used for Rheumatoid arthritis, Systemic lupus erythematosus, Polymyalgia rheumatica.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}